<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">Diabetes mellitus is characterized by hyperglycemia which is caused by defects in insulin secretion, its action or both (
 <xref rid="bib50" ref-type="bibr">Kharroubi and Darwish, 2015</xref>). Alpha-glucosidase and aldose reductase are emerging metabolic targets for the treatment of patients with impaired glucose tolerance and diabetes (
 <xref rid="bib29" ref-type="bibr">Grewal et al., 2016</xref>). Herbal medicines have a long history for the treatment of diabetes as compared to conventional medicine (
 <xref rid="bib20" ref-type="bibr">Choudhury et al., 2018</xref>). Hispolon, a natural polyphenolic compound possesses strong antidiabetic properties (
 <xref rid="bib15" ref-type="bibr">Chen et al., 2013</xref>). Hispolon exhibited potent activity against α-glucosidase (IC
 <sub>50</sub> = 12.38 μg/mL) and aldose reductase (IC
 <sub>50</sub> = 9.47 μg/mL). These findings suggest that hispolon might serve as an attractive scaffold for anti-diabetic drugs (
 <xref rid="bib41" ref-type="bibr">Huang et al., 2011a</xref>).
</p>
